1-3 of 3
David Macari
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcome of Patients with Newly-Diagnosed Therapy-Related AML (t-AML) and AML with Myelodysplasia-Related Changes (AML-MRC) Treated with Liposomal Daunorubicin and Cytarabine (CPX-351) at an Academic Community-Based Health System

John Khoury, MD, Nwabundo Anusim, MD, David Macari, MD, Angela Duenn, PharmD, Ishmael Jaiyesimi, DO, MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 5117.
https://doi.org/10.1182/blood-2019-130776
Published: 2019
Journal Articles

Outcome of Lymphocyte Predominant Hodgkin Lymphoma: A Single Institutional Analysis

Daniel E Ezekwudo, MD, Nwabundo Anusim, MD MPH, Anish S Konde, MD, Bolanle Gbadamosi, MD, John Khoury, MD, David Macari, MD, Dana Zakalik, MD, Leann Blankenship, MD, Susanna Gaikazian, MD, Ishmael Jaiyesimi, DO, MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 5376.
https://doi.org/10.1182/blood-2018-99-116702
Published: 2018
Journal Articles

Vascular Access Device Complications during Induction Chemotherapy for AML: A Single Institutional Analysis

David Macari, MD, Bolanle Gbadamosi, MD, Daniel E Ezekwudo, MD, Joseph Anderson, MD, Ishmael Jaiyesimi, DO, MS, Michael Stender, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3529.
https://doi.org/10.1182/blood-2018-99-116980
Published: 2018